Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paesmans

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|September 17, 2002
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysisA-P Meert, M Paesmans, B Martin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2019
Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancerM T Genot-Klastersky, M Paesmans, L Ameye, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.comJ P Sculier, J J Lafitte, T Berghmans, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
Cancer|April 1, 1990
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancerJ J Body, J P Sculier, N Raymakers, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancerR Feld, R Abratt, S Graziano, et al.
BMC Cancer|July 4, 2001
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisA P Meert, M Paesmans, T Berghmans, et al.
British Journal of Cancer|September 11, 2003
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literatureA-P Meert, B Martin, M Paesmans, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|September 17, 2002
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysisA-P Meert, M Paesmans, B Martin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 11, 2019
Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancerM T Genot-Klastersky, M Paesmans, L Ameye, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.comJ P Sculier, J J Lafitte, T Berghmans, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
Cancer|April 1, 1990
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancerJ J Body, J P Sculier, N Raymakers, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancerR Feld, R Abratt, S Graziano, et al.
BMC Cancer|July 4, 2001
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisA P Meert, M Paesmans, T Berghmans, et al.
British Journal of Cancer|September 11, 2003
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literatureA-P Meert, B Martin, M Paesmans, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Pageof 19